| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76420-210-10 | 76420-210 | HUMAN PRESCRIPTION DRUG | Nabumetone | Nabumetone | TABLET | ORAL | 20220308 | N/A | ANDA | ANDA078420 | Asclemed USA, Inc. | NABUMETONE | 500 mg/1 | 10 TABLET in 1 BOTTLE (76420-210-10) |
| 76420-210-14 | 76420-210 | HUMAN PRESCRIPTION DRUG | Nabumetone | Nabumetone | TABLET | ORAL | 20220308 | N/A | ANDA | ANDA078420 | Asclemed USA, Inc. | NABUMETONE | 500 mg/1 | 14 TABLET in 1 BOTTLE (76420-210-14) |
| 76420-210-20 | 76420-210 | HUMAN PRESCRIPTION DRUG | Nabumetone | Nabumetone | TABLET | ORAL | 20220308 | N/A | ANDA | ANDA078420 | Asclemed USA, Inc. | NABUMETONE | 500 mg/1 | 20 TABLET in 1 BOTTLE (76420-210-20) |
| 76420-210-30 | 76420-210 | HUMAN PRESCRIPTION DRUG | Nabumetone | Nabumetone | TABLET | ORAL | 20220308 | N/A | ANDA | ANDA078420 | Asclemed USA, Inc. | NABUMETONE | 500 mg/1 | 30 TABLET in 1 BOTTLE (76420-210-30) |
| 76420-210-60 | 76420-210 | HUMAN PRESCRIPTION DRUG | Nabumetone | Nabumetone | TABLET | ORAL | 20220308 | N/A | ANDA | ANDA078420 | Asclemed USA, Inc. | NABUMETONE | 500 mg/1 | 60 TABLET in 1 BOTTLE (76420-210-60) |